Live
- Visakhapatnam: TDP Bheemili candidate takes part in devotional programmes
- Education dept struggles with staff shortages in RR dist
- AltStore PAL, a Third-Party iPhone App Store, Launches in Europe
- Biomining technology for cleaning up Solipur dumpyard: Shadnagar MLA
- Visakhapatnam: Inter Services Water Polo Championship held
- Deer dies in dog's attack in Kothur
- PM will lose if elections held using ballot papers: Revanth
- Visakhapatnam: The lost glory of Congress will be revived says Cong LS candidate
- LS nominations to be filed from today
- Mangalagiri: Let’s put an end to evil rule says Pawan Kalyan
Five more Covid vaccines in pipeline
Five more Covid vaccines in pipeline
Johnson & Johnson, Sputnik V expected by Oct
The Centre is gearing to scale up the Covid-19 vaccine production as more and more States flag shortage of vaccine doses. It is expected that by the end of the third quarter of 2021, India will get five additional vaccine manufacturers apart from current manufactures Covishield and Covaxin.
Around 20 Covid-19 vaccines are in various clinical and pre-clinical stages and will add a boost to India's vaccine production. As per top government sources, the new strategy is to manufacture additional vaccine doses.
"These vaccines are Sputnik V vaccine (in collaboration with Dr Reddy's), Johnson & Johnson vaccine (in collaboration with Biological E), Novavax vaccine (in collaboration with Serum India), Zydus Cadila's vaccine, and Bharat Biotech's intranasal vaccine," a source was quoted as saying. Sputnik V vaccine is expected to get the Emergency Use Approval (EUA) within the next ten days.
